| JYHZ1700230 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | License Renew | 2018-01-19 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2018-03-28 | view |
| JYHB2200081 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2022-02-15 | | | | | view |
| JXHS0700025 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs(3.1) | Import Drug Application | 2007-05-31 | Pfizer Italia s.r.l. | Pfizer Italia SRL | Certificate Issued | 2008-06-26 | view |
| JYHB1400901 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2014-07-04 | Pfizer Italia s.r.l | Pfizer Italia SRL | Certificate Issued | 2015-03-03 | view |
| JYHB2001321 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2020-08-21 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2020-12-30 | view |
| A20020027 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | New Drug Application | 2002-04-01 | 法玛西亚普强(中国)有限公司 | Pfizer Investment Co Ltd | Approval Completed-Pending Certificated | 2003-04-25 | view |
| CYHS2300422 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs(4) | Generic Drug | 2023-02-09 | | Yichang Humanwell Pharmaceutical Co Ltd | | | view |
| JYHB1201252 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2012-11-09 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2013-06-13 | view |
| JYHZ1700231 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | License Renew | 2018-01-19 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2018-03-28 | view |
| JYHB2200082 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2022-02-15 | | | | | view |
| CXHL0601048 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs(5) | New Drug Application | 2007-01-10 | 广东中大南海海洋生物技术工程中心有限公司 | Guangdong Zhongda Nanhai Ocean Biological Technology Engineering Centre Co Ltd | Certificate Issued | 2009-07-21 | view |
| JYHB1400900 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2014-07-04 | Pfizer Italia s.r.l | Pfizer Italia SRL | Certificate Issued | 2015-03-03 | view |
| JYHB2001320 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2020-08-10 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2020-12-30 | view |
| CYHS2300423 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs(4) | Generic Drug | 2023-02-09 | | Yichang Humanwell Pharmaceutical Co Ltd | | | view |
| JYHB1201250 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2012-11-09 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2013-06-13 | view |
| JYHB2001374 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2020-08-21 | 辉瑞制药有限公司 | Pfizer Pharmaceuticals Ltd | Filed | 2020-09-02 | view |
| X0405594 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs(5) | New Drug Application | 2004-09-30 | 深圳市海滨制药有限公司 | Shenzhen Haibin Pharmaceutical Co Ltd | Certificate Issued | 2005-11-03 | view |
| CYHS2402399 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs(4) | Generic Drug | 2024-07-30 | | Shijiazhuang NO4 Pharmaceutical Co Ltd | | | view |
| JYHB1801285 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2018-11-12 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2018-12-05 | view |
| JYHB2101341 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2021-08-19 | | | | | view |
